Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POPular STRATEGY PD
2023-504078-39-01Phase 4Completed
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ticagrelor, clopidogrel, prasugrel and aspirin in coronary arteriosclerosis and Chronic Coronary Syndrome (CCS) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Platelet inhibition measured by PRU using VerifyNow at 30 days. Started Jun 2023; status: completed.
02
Drugs
ticagrelorclopidogrelprasugrelaspirin
03
Conditions
coronary arteriosclerosisChronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on 2023-504078-39-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504078-39-01.